Structure-based methods to predict mutational resistance to diarylpyrimidine non-nucleoside reverse transcriptase inhibitors

2018

• Diarylpyrimidine (DAPY) NNRTIs used in treatment and prevention therapy are greatly affected by resistance-associated mutations.

Keywords:

References

Citations